CRISPR-Cas9: Prospects and Challenges

Human Gene Therapy
Feng Zhang

Abstract

No abstract listed.

Citations

Nov 28, 2015·Genome Biology·Daniel B Graham, David E Root
Jan 20, 2017·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Veronica Lau, James R Davie
Dec 13, 2016·Angewandte Chemie·Simon AusländerMartin Fussenegger
Jun 14, 2017·Human Gene Therapy. Clinical Development·Dongsheng Duan
Jan 18, 2018·Human Gene Therapy·Zhi-Yao HeYu-Quan Wei
Aug 5, 2016·Asia-Pacific Journal of Ophthalmology·Keryn A Williams, Yazad D Irani
Jul 26, 2017·Nature Communications·Xionggao HuangHetian Lei
Aug 25, 2016·Angewandte Chemie·Piyush K JainSangeeta N Bhatia
Jul 14, 2018·Chromosoma·Yutaka Yamamoto, Susan A Gerbi
Dec 29, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Neelam YadavJogender Singh Rana
Mar 23, 2021·Cellular and Molecular Life Sciences : CMLS·Patrícia Martins-Dias, Luísa Romão
Jan 4, 2018·Bioconjugate Chemistry·Moumita RayVincent M Rotello
Sep 28, 2021·Current Protocols·Muhan HeMaksim Royzen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.